Published on September 9, 2009 at 5:56 AM
Reportlinker.com announces that a new market research report is available in its catalogue: Lung Cancer Therapeutics
http://www.reportlinker.com/p0131247/Lung-Cancer-Therapeutics.html
This report analyzes the worldwide markets (Annual Revenues) for Lung Cancer Therapeutics in Millions of US$. The US market for Non-Small Cell Lung Cancer treatment is further analyzed by: Chemotherapy Drugs, and Targeted Drugs. The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual forecasts are provided for each region for the period 2005 through 2015. The report profiles 191 companies including many key and niche players worldwide such as AstraZeneca PLC., Bristol-Myers Squibb Co., Eli Lilly & Co., F. Hoffmann-La Roche Ltd., Genentech, Inc., GlaxoSmithKline Plc., Novartis Pharmaceuticals Corporation, OSI Pharmaceuticals, Inc., Sanofi-Aventis, AbGenomics International Inc., ImClone Systems, Inc., Pfizer, Inc., Merck Serono International S.A., Merck & Co. Ltd., Telik, Inc., and Woomera Therapeutics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Source: http://www.reportlinker.com
6f9034d8-b45c-4e32-b89b-4b1bec59f204|0|.0
Posted in: Medical Condition News
Tags: Abraxane, Alimta, Antibody, Avastin, Cancer, Carboplatin, Cediranib, Cell, Cetuximab, Chemotherapy, Cisplatin, Erlotinib, Gefitinib, Gemcitabine, Iressa, Irinotecan, Lung Cancer, Monoclonal Antibody, Nexavar, Non-Small Cell Lung Cancer, Paclitaxel, Pfizer, Photodynamic Therapy, Small Cell Lung Cancer, Sorafenib, Sunitinib, Tarceva, Vaccine, Vandetanib, VEGF, Vinflunine, Vinorelbine, Xyotax, Zactima, Zolinza